| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
An analysis of FDA-approved drugs for metabolic diseases
|
Kinch, Michael S.
|
|
2015
|
20 |
6 |
p. 648-651
4 p.
|
artikel
|
| 2 |
Cancer drug development in China: recent advances and future challenges
|
Wu, Yi-Long
|
|
2015
|
20 |
6 |
p. 766-771
6 p.
|
artikel
|
| 3 |
Contents page 1
|
|
|
2015
|
20 |
6 |
p. i-
1 p.
|
artikel
|
| 4 |
Contents page 2
|
|
|
2015
|
20 |
6 |
p. iii-
1 p.
|
artikel
|
| 5 |
Extending kinome coverage by analysis of kinase inhibitor broad profiling data
|
Jacoby, Edgar
|
|
2015
|
20 |
6 |
p. 652-658
7 p.
|
artikel
|
| 6 |
Histone deacetylases: structural determinants of inhibitor selectivity
|
Micelli, Carmina
|
|
2015
|
20 |
6 |
p. 718-735
18 p.
|
artikel
|
| 7 |
How the flexibility of human histone deacetylases influences ligand binding: an overview
|
Deschamps, Nathalie
|
|
2015
|
20 |
6 |
p. 736-742
7 p.
|
artikel
|
| 8 |
How to mend a broken heart: adult and induced pluripotent stem cell therapy for heart repair and regeneration
|
Wegener, Marie
|
|
2015
|
20 |
6 |
p. 667-685
19 p.
|
artikel
|
| 9 |
Pharmaceutical and biomedical applications of surface engineered carbon nanotubes
|
Mehra, Neelesh Kumar
|
|
2015
|
20 |
6 |
p. 750-759
10 p.
|
artikel
|
| 10 |
Potential of yeast secretory vesicles in biodelivery systems
|
Kutralam-Muniasamy, Gurusamy
|
|
2015
|
20 |
6 |
p. 659-666
8 p.
|
artikel
|
| 11 |
Preclinical and clinical evidence for stem cell therapies as treatment for diabetic wounds
|
Heublein, Hannes
|
|
2015
|
20 |
6 |
p. 703-717
15 p.
|
artikel
|
| 12 |
Protection from noise-induced hearing loss with Src inhibitors
|
Bielefeld, Eric C.
|
|
2015
|
20 |
6 |
p. 760-765
6 p.
|
artikel
|
| 13 |
Structural definitions of Jumonji family demethylase selectivity
|
Pilka, Ewa S.
|
|
2015
|
20 |
6 |
p. 743-749
7 p.
|
artikel
|
| 14 |
The impact of molecular dynamics on drug design: applications for the characterization of ligand–macromolecule complexes
|
Mortier, Jérémie
|
|
2015
|
20 |
6 |
p. 686-702
17 p.
|
artikel
|
| 15 |
There is no better time than the present: nanotechnology as a disruptive innovation for drug development
|
Oo, Charles
|
|
2015
|
20 |
6 |
p. 645-647
3 p.
|
artikel
|
| 16 |
Toward an effective strategy in glioblastoma treatment. Part II: RNA interference as a promising way to sensitize glioblastomas to temozolomide
|
Messaoudi, Khaled
|
|
2015
|
20 |
6 |
p. 772-779
8 p.
|
artikel
|
Tijdschrift beschrijving